These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31421125)

  • 1. Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis.
    Liu H; Kang RS; Bagnowski K; Yu JM; Radecki S; Daniel WL; Anderson BR; Nallagatla S; Schook A; Agarwal R; Giljohann DA; Paller AS
    J Invest Dermatol; 2020 Feb; 140(2):435-444.e4. PubMed ID: 31421125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Regulation Using Spherical Nucleic Acids to Treat Skin Disorders.
    Holmes TR; Paller AS
    Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33147737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
    J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
    Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
    Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Okura I; Kamata M; Asano Y; Mitsui A; Shimizu T; Sato S; Tada Y
    J Dermatol Sci; 2021 May; 102(2):116-125. PubMed ID: 33888401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.
    Imura C; Ueyama A; Sasaki Y; Shimizu M; Furue Y; Tai N; Tsujii K; Katayama K; Okuno T; Shichijo M; Yasui K; Yamamoto M
    J Dermatol Sci; 2019 Mar; 93(3):176-185. PubMed ID: 30905492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on Psoriasis.
    Korkmaz E; Falo LD
    J Invest Dermatol; 2020 Feb; 140(2):278-281. PubMed ID: 31980061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.
    Smith SH; Peredo CE; Takeda Y; Bui T; Neil J; Rickard D; Millerman E; Therrien JP; Nicodeme E; Brusq JM; Birault V; Viviani F; Hofland H; Jetten AM; Cote-Sierra J
    PLoS One; 2016; 11(2):e0147979. PubMed ID: 26870941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
    Tu J; Yin Z; Guo J; He F; Long F; Yin Z
    Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
    Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
    PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
    Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY
    Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model.
    Choi CW; Kim BR; Yang S; Kim Y; Kang JS; Youn SW
    J Dermatol Sci; 2020 Jun; 98(3):199-202. PubMed ID: 32451152
    [No Abstract]   [Full Text] [Related]  

  • 19. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
    Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
    Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.